Skip to content
← Back to this collection

PUBLICATIONS · 14576047

Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2004 Feb 15
First author
Sanz MA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Sanz MA
      type
      Author
    2. name
      Martín G
      type
      Author
    3. name
      González M
      type
      Author
    4. name
      León A
      type
      Author
    5. name
      Rayón C
      type
      Author
    6. name
      Rivas C
      type
      Author
    7. name
      Colomer D
      type
      Author
    8. name
      Amutio E
      type
      Author
    9. name
      Capote FJ
      type
      Author
    10. name
      Milone GA
      type
      Author
    11. name
      De La Serna J
      type
      Author
    12. name
      Román J
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Sanz MA
      type
      Author
    2. name
      Martín G
      type
      Author
    3. name
      González M
      type
      Author
    4. name
      León A
      type
      Author
    5. name
      Rayón C
      type
      Author
    6. name
      Rivas C
      type
      Author
    7. name
      Colomer D
      type
      Author
    8. name
      Amutio E
      type
      Author
    9. name
      Capote FJ
      type
      Author
    10. name
      Milone GA
      type
      Author
    11. name
      De La Serna J
      type
      Author
    12. name
      Román J
      type
      Author
    bibliography ids
    1. nci-bib-69bdce24537f6adf9a3d70cd
    book metadata
    content sha256
    0583e92e39fb5dc7303a188adfd1701e129d9d3c34fbc5d1d7f97746a53c1215
    document type
    citation
    dois
    1. 10.1182/blood-2003-07-2462
    electronic publication date
    display
    2003 Oct 23
    precision
    day
    year
    2003
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:14576047
    immutable id
    pubmed:14576047@0583e92e39fb5dc7303a188adfd1701e129d9d3c34fbc5d1d7f97746a53c1215
    journal
    abbreviation
    Blood
    issn electronic
    Source null
    issn print
    0006-4971
    issue
    4
    name
    Blood
    nlm unique id
    7603509
    pages
    1237-43
    volume
    103
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      14576047
      provenance
      batch id
      aee154f17d1b0501fe1f
      provider
      NCBI PubMed ESummary
      record sha256
      499435008efefe4132da59afb74c7cff6463dd4f0616f83a3603181b78ab0746
      response sha256
      75a826407a9022d376294c7400982e19a458458cea55b2628fd3fddd75bc0f08
      retrieved at
      2026-09-09T23:45:53.270896+00:00
      publication date
      display
      2004 Feb 15
      precision
      day
      year
      2004
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/14576047/
      title
      Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group.

      Preserved source evidence · Not medical advice